Anastasia Khvorova
Affiliations: | RNA Therapeutics Institute | University Of Massachusetts Med Sch Worcester |
Google:
"Anastasia Khvorova"Mean distance: (not calculated yet)
Children
Sign in to add traineeReka Agnes Haraszti | grad student | 2014-2018 | University Of Massachusetts Med Sch Worcester |
Daniel O'Reilly | post-doc | 2020- | University of Massachusetts Medical School, USA (Chemistry Tree) |
Bruno M.D.C. Godinho | post-doc | 2015-2019 | University Of Massachusetts Med Sch Worcester |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ferguson CM, Godinho BMDC, Echeverria D, et al. (2024) A combinatorial approach for achieving CNS-selective RNAi. Nucleic Acids Research |
Fakih HH, Tang Q, Summers A, et al. (2023) Dendritic amphiphilic siRNA: Selective albumin binding, efficacy, and low toxicity. Molecular Therapy. Nucleic Acids. 34: 102080 |
Zhang H, Kelly K, Lee J, et al. (2023) Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo. Nucleic Acids Research |
Engelbeen S, O'Reilly D, Van De Vijver D, et al. (2023) Challenges of Assessing Exon 53 Skipping of the Human Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 33: 348-360 |
O'Reilly D, Belgrad J, Ferguson C, et al. (2023) Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Hariharan VN, Caiazzi J, Miller R, et al. (2023) Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo. Research Square |
Yamada K, Hariharan VN, Caiazzi J, et al. (2023) Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy . Biorxiv : the Preprint Server For Biology |
O'Reilly D, Belgrad J, Ferguson C, et al. (2023) Di-valent siRNA Mediated Silencing of MSH3 Blocks Somatic Repeat Expansion in Mouse Models of Huntington's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Zhang H, Kelly K, Lee J, et al. (2023) Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing . Biorxiv : the Preprint Server For Biology |
Hariharan VN, Shin M, Chang CW, et al. (2023) Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America. 120: e2219523120 |